Palache A, Abelin A, Hollingsworth R, Cracknell W, Jacobs C, Tsai T, Barbosa P
Consultant at Abbott, C.J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands.
Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007, France.
Vaccine. 2017 Aug 24;35(36):4681-4686. doi: 10.1016/j.vaccine.2017.07.053. Epub 2017 Jul 25.
There is no global monitoring system for influenza vaccination coverage, making it difficult to assess progress towards the 2003 World Health Assembly (WHA) vaccination coverage target. In 2008, the IFPMA Influenza Vaccine Supply International Task Force (IVS) developed a survey method to assess the global distribution of influenza vaccine doses as a proxy for vaccination coverage rates. The latest dose distribution data for 2014 and 2015 was used to update previous analyses. Data were confidentially collected and aggregated by the IFPMA Secretariat, and combined with previous IFPMA IVS survey data (2004-2013). Data were available from 201 countries over the 2004-2015 period. A "hurdle" rate was defined as the number of doses required to reach 15.9% of the population in 2008. Overall, the number of distributed doses progressively increased between 2004 and 2011, driven by a 150% increase in AMRO, then plateaued. One percent fewer doses were distributed in 2015 than in 2011. Twenty-three countries were above the hurdle rate in 2015, compared to 15 in 2004, but distribution was highly uneven in and across all WHO regions. Three WHO regions (AMRO, EURO and WPRO) accounted for about 95% of doses distributed. But in EURO and WPRO, distribution rates in 2015 were only marginally higher than in 2004, and in EURO there was an overall downward trend in dose distribution. The vast majority of countries cannot meet the 2003WHA coverage targets and are inadequately prepared for a global influenza pandemic. With only 5% of influenza vaccine doses being distributed to 50% of the world's population, there is urgency to redress the gross inequities in disease prevention and in pandemic preparedness. The 2003WHA resolution must be reviewed and revised and a call issued for the renewed commitment of Member States to influenza vaccination coverage targets.
目前尚无针对流感疫苗接种覆盖率的全球监测系统,因此难以评估在实现2003年世界卫生大会(WHA)设定的疫苗接种覆盖率目标方面所取得的进展。2008年,国际制药商协会联合会(IFPMA)流感疫苗供应国际特别工作组(IVS)开发了一种调查方法,以评估全球流感疫苗剂量的分配情况,作为疫苗接种覆盖率的替代指标。利用2014年和2015年最新的剂量分配数据对之前的分析进行了更新。数据由IFPMA秘书处秘密收集和汇总,并与IFPMA IVS之前的调查数据(2004 - 2013年)相结合。在2004 - 2015年期间,有201个国家提供了数据。“门槛”率定义为在2008年达到人口15.9%所需的疫苗剂量数。总体而言,在2004年至2011年期间,分发的疫苗剂量数量逐渐增加,这主要是由于美洲区域办事处(AMRO)的分发量增长了150%,之后趋于平稳。2015年分发的剂量比2011年少1%。2015年有23个国家超过了门槛率,而2004年为15个国家,但在世卫组织所有区域内和区域间的分配极不均衡。世卫组织三个区域(AMRO、欧洲区域办事处(EURO)和西太平洋区域办事处(WPRO))约占分发剂量的95%。但在EURO和WPRO,2015年的分配率仅略高于2004年,并且在EURO,剂量分配总体呈下降趋势。绝大多数国家无法实现2003年WHA设定的覆盖率目标,并且在应对全球流感大流行方面准备不足。由于仅5%的流感疫苗剂量分发给了世界50%的人口,因此迫切需要纠正疾病预防和大流行防范方面的严重不平等现象。必须对WHA 2003年的决议进行审查和修订,并呼吁会员国重新致力于实现流感疫苗接种覆盖率目标。